Comprehensive Technical Analysis of EUVD-2026-2994 (CVE-2025-64691)

Vulnerability in AVEVA Process Optimization (Privilege Escalation via TCL Macro Script Tampering)

---

1. Vulnerability Assessment & Severity Evaluation

Vulnerability Overview

EUVD-2026-2994 (CVE-2025-64691) is a privilege escalation vulnerability in AVEVA Process Optimization software, allowing an authenticated standard OS user to manipulate TCL (Tool Command Language) Macro scripts, leading to arbitrary code execution with SYSTEM-level privileges. Successful exploitation could result in full compromise of the affected application server, including unauthorized access, data exfiltration, or lateral movement within an industrial control system (ICS) network.

CVSS v4.0 Severity Analysis

Metric	Value	Explanation
Base Score	9.3 (Critical)	High impact on confidentiality, integrity, and availability.
Attack Vector (AV)	L (Local)	Exploitation requires local access to the system.
Attack Complexity (AC)	L (Low)	No specialized conditions required; straightforward exploitation.
Attack Requirements (AT)	N (None)	No additional prerequisites beyond standard user access.
Privileges Required (PR)	L (Low)	Attacker only needs standard OS user privileges.
User Interaction (UI)	N (None)	No user interaction required.
Vulnerable Confidentiality (VC)	H (High)	Complete compromise of sensitive data.
Vulnerable Integrity (VI)	H (High)	Unauthorized modification of critical system components.
Vulnerable Availability (VA)	H (High)	Full system disruption possible.
Subsequent Confidentiality (SC)	H (High)	Post-exploitation impact extends to other systems.
Subsequent Integrity (SI)	H (High)	Persistent backdoors or malware deployment possible.
Subsequent Availability (SA)	H (High)	Denial-of-service or ransomware deployment possible.

Key Takeaways:

• Critical severity (9.3) due to low attack complexity, high impact, and local privilege escalation (LPE) potential.
• No user interaction required, making it attractive for insider threats or post-compromise exploitation.
• High subsequent impact suggests lateral movement and persistence risks in ICS environments.

---

2. Potential Attack Vectors & Exploitation Methods

Exploitation Prerequisites

• Authenticated local access (standard OS user privileges).
• AVEVA Process Optimization installed (versions ≤ 2024.1).
• TCL Macro script execution enabled in the application.

Attack Vectors

A. TCL Macro Script Manipulation (Primary Exploitation Path)

1. Identify Vulnerable TCL Scripts

   • The attacker locates writable TCL scripts used by AVEVA Process Optimization (e.g., in C:\Program Files\AVEVA\Process Optimization\Macros\).
   • Scripts may be executed with elevated privileges (SYSTEM or admin context).

2. Inject Malicious Payload

   • The attacker modifies an existing TCL script or creates a new one with arbitrary commands (e.g., PowerShell, CMD, or direct system calls).
   • Example payload:

     exec cmd.exe /c "net user attacker P@ssw0rd123 /add && net localgroup administrators attacker /add"
     

   • Alternatively, reverse shell payloads (e.g., via nc.exe, PowerShell Empire, or Cobalt Strike).

3. Trigger Script Execution

   • The attacker waits for the script to execute (e.g., via scheduled tasks, application workflows, or manual triggers).
   • If the script runs in a privileged context, the payload executes with SYSTEM-level permissions.

B. DLL Hijacking or Side-Loading (Secondary Exploitation Path)

• If TCL scripts load external DLLs, an attacker could:
  • Replace a legitimate DLL with a malicious one (e.g., msvcrt.dll).
  • Exploit weak file permissions to plant a DLL in a writable directory.
• Upon script execution, the malicious DLL executes with elevated privileges.

C. Persistence & Lateral Movement

• Post-exploitation, the attacker may:
  • Deploy backdoors (e.g., scheduled tasks, WMI subscriptions).
  • Exfiltrate sensitive ICS data (e.g., process configurations, credentials).
  • Move laterally to other systems in the OT network.

---

3. Affected Systems & Software Versions

Vulnerable Products

Vendor	Product	Affected Versions	Fixed Versions
AVEVA	Process Optimization	≤ 2024.1	2024.2+ (Patch available)

Deployment Context

• Industrial Control Systems (ICS) – Commonly used in oil & gas, manufacturing, water treatment, and energy sectors.
• Windows-based environments – Typically deployed on Windows Server 2016/2019/2022 or Windows 10/11 workstations.
• OT/IT Convergence – May be exposed to corporate networks, increasing attack surface.

---

4. Recommended Mitigation Strategies

Immediate Actions (Short-Term)

✅ Apply AVEVA Security Patches

• Upgrade to AVEVA Process Optimization 2024.2 or later (see AVEVA Security Updates).
• If patching is delayed, apply workarounds (see below).

✅ Restrict TCL Script Permissions

• Remove write permissions for standard users on TCL script directories:

  icacls "C:\Program Files\AVEVA\Process Optimization\Macros\" /deny "Users:(W)"
  

• Audit script execution via Windows Event Logs (Event ID 4688).

✅ Least Privilege Enforcement

• Restrict standard users from running AVEVA Process Optimization with admin rights.
• Implement application whitelisting (e.g., Microsoft AppLocker, WDAC).

✅ Network Segmentation & Isolation

• Isolate ICS networks from corporate IT using firewalls, VLANs, and DMZs.
• Disable unnecessary services (e.g., SMB, RDP) on AVEVA servers.

Long-Term Mitigations

🔹 Enhanced Monitoring & Detection

• Deploy EDR/XDR solutions (e.g., Microsoft Defender for Endpoint, CrowdStrike) to detect unusual TCL script modifications.
• Monitor for privilege escalation attempts (e.g., SeDebugPrivilege abuse, Token Impersonation).

🔹 Secure Development Practices

• AVEVA should enforce:
  • Code signing for TCL scripts to prevent unauthorized modifications.
  • Sandboxing of script execution (e.g., running in a low-privilege context).
  • Automated vulnerability scanning in CI/CD pipelines.

🔹 Incident Response Planning

• Develop playbooks for ICS-specific attacks, including:
  • TCL script tampering detection.
  • Privilege escalation containment.
  • Forensic analysis of affected systems.

🔹 Third-Party Risk Management

• Audit third-party integrations (e.g., plugins, custom scripts) for similar vulnerabilities.
• Enforce secure coding standards for vendors supplying TCL scripts.

---

5. Impact on European Cybersecurity Landscape

Sector-Specific Risks

Sector	Potential Impact	Regulatory Implications
Energy (Oil & Gas, Electricity)	Disruption of critical infrastructure, potential blackouts.	NIS2 Directive (EU 2022/2555) – Mandatory reporting, fines up to €10M or 2% of global turnover.
Water Treatment	Contamination risks, public health hazards.	EU Water Framework Directive – Compliance violations.
Manufacturing (Industry 4.0)	Production halts, intellectual property theft.	EU Cyber Resilience Act (CRA) – Liability for insecure products.
Transportation (Rail, Airports)	Safety risks, operational disruptions.	EU Critical Entities Resilience Directive (CER) – Mandatory risk assessments.

Broader Implications

• Supply Chain Risks: AVEVA is widely used in European critical infrastructure, making this a high-priority threat for ENISA, CERT-EU, and national CSIRTs.
• OT/IT Convergence Challenges: Many ICS environments lack proper segmentation, increasing the risk of lateral movement from IT to OT networks.
• Compliance & Liability: Organizations failing to patch may face regulatory penalties under GDPR, NIS2, and sector-specific laws.
• Threat Actor Interest: APT groups (e.g., Sandworm, APT29) and ransomware gangs (e.g., LockBit, Black Basta) may exploit this in targeted attacks.

ENISA & CERT-EU Recommendations

• Immediate patching of affected AVEVA systems.
• Enhanced monitoring of ICS networks for unusual TCL script activity.
• Collaboration with CERTs (e.g., CERT-EU, national CSIRTs) for threat intelligence sharing.
• Tabletop exercises to test ICS incident response plans.

---

6. Technical Details for Security Professionals

Root Cause Analysis

• Vulnerability Type: Privilege Escalation via Insecure Script Execution.
• CWE Classification: CWE-78: Improper Neutralization of Special Elements used in an OS Command (OS Command Injection).
• Underlying Issue:
  • AVEVA Process Optimization executes TCL scripts with elevated privileges without proper input validation or sandboxing.
  • Standard users can modify scripts, leading to arbitrary command execution in a privileged context.

Exploitation Proof of Concept (PoC)

(For authorized testing only – do not use maliciously.)

1. Identify a writable TCL script (e.g., C:\Program Files\AVEVA\Process Optimization\Macros\example.tcl).
2. Append a malicious payload:

   # Malicious TCL payload (adds a local admin)
   exec cmd.exe /c "net user pocuser P@ssw0rd123 /add && net localgroup administrators pocuser /add"
   

3. Trigger script execution (e.g., via application workflow or scheduled task).
4. Verify privilege escalation:

   net user pocuser
   

   • If successful, pocuser will be in the Administrators group.

Detection & Forensics

Detection Method	Tool/Technique	Indicators of Compromise (IoCs)
File Integrity Monitoring (FIM)	Windows Event ID 4663 (File Modification)	Unauthorized changes to .tcl files.
Process Monitoring	Sysmon Event ID 1 (Process Creation)	cmd.exe or powershell.exe spawned by AVEVA processes.
Privilege Escalation Detection	Windows Event ID 4672 (Special Privileges Assigned)	Unusual privilege assignments (e.g., SeDebugPrivilege).
Script Execution Logs	AVEVA Application Logs	Unexpected TCL script executions.
Network Traffic Analysis	Zeek/Suricata	Unusual outbound connections (e.g., C2 callbacks).

YARA Rule for Malicious TCL Scripts

rule AVEVA_TCL_PrivilegeEscalation {
    meta:
        description = "Detects malicious TCL scripts used for privilege escalation in AVEVA Process Optimization"
        author = "Cybersecurity Analyst"
        reference = "CVE-2025-64691"
        severity = "Critical"

    strings:
        $cmd1 = "net user" nocase
        $cmd2 = "net localgroup" nocase
        $cmd3 = "whoami /all" nocase
        $cmd4 = "powershell" nocase
        $cmd5 = "cmd.exe /c" nocase
        $tcl_exec = "exec " nocase

    condition:
        (uint16(0) == 0x2321) and // TCL scripts often start with "#!"
        (2 of ($cmd*)) and $tcl_exec
}

Hardening Recommendations

• Disable TCL script execution if not required.
• Enforce script signing (e.g., via Windows Code Signing).
• Implement application control (e.g., Microsoft AppLocker).
• Enable Windows Defender Attack Surface Reduction (ASR) rules:

  Add-MpPreference -AttackSurfaceReductionRules_Ids BE9BA2D9-53EA-4CDC-84E5-9B1EEEE46550 -AttackSurfaceReductionRules_Actions Enabled
  

• Deploy ICS-specific EDR (e.g., Nozomi Networks, Dragos, Claroty).

---

Conclusion & Actionable Recommendations

EUVD-2026-2994 (CVE-2025-64691) represents a critical privilege escalation risk in AVEVA Process Optimization, with severe implications for European critical infrastructure. Organizations must:

✔ Patch immediately (AVEVA 2024.2+). ✔ Restrict TCL script permissions and monitor for tampering. ✔ Enforce least privilege and network segmentation. ✔ Enhance detection via EDR/XDR and SIEM solutions. ✔ Prepare for regulatory reporting under NIS2, GDPR, and sector-specific laws.

Failure to mitigate this vulnerability could result in:

• Complete system compromise (SYSTEM-level access).
• Lateral movement into OT networks.
• Regulatory fines and reputational damage.

Next Steps for Security Teams:

1. Inventory all AVEVA Process Optimization deployments.
2. Apply patches or workarounds within 72 hours (critical severity).
3. Conduct a post-patch validation to ensure remediation.
4. Report to CERT-EU or national CSIRT if exploitation is detected.

For further details, refer to:

• CISA ICS Advisory (ICSA-26-015-01)
• AVEVA Security Updates
• NVD Entry (CVE-2025-64691)